0001613386-14-000001.txt : 20140711 0001613386-14-000001.hdr.sgml : 20140711 20140710173956 ACCESSION NUMBER: 0001613386-14-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140711 DATE AS OF CHANGE: 20140710 EFFECTIVENESS DATE: 20140711 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aminex Therapeutics, Inc. CENTRAL INDEX KEY: 0001613386 IRS NUMBER: 263969765 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-220780 FILM NUMBER: 14970340 BUSINESS ADDRESS: STREET 1: 11335 NE 122ND STREET 2: SUITE 105 CITY: KIRKLAND STATE: WA ZIP: 98034 BUSINESS PHONE: 425-286-4222 MAIL ADDRESS: STREET 1: 11335 NE 122ND STREET 2: SUITE 105 CITY: KIRKLAND STATE: WA ZIP: 98034 D 1 primary_doc.xml X0707 D LIVE 0001613386 Aminex Therapeutics, Inc. 11335 NE 122ND SUITE 105 KIRKLAND WA WASHINGTON 98034 425-286-4222 WASHINGTON None None Corporation true Thomas Graham 11335 NE 122nd Suite 105 Kirkland WA WASHINGTON 98034 Executive Officer Director John Rosling 11335 NE 122nd Suite 105 Kirkland WA WASHINGTON 98034 Director James Skaggs 11335 NE 122nd Suite 105 Kirkland WA WASHINGTON 98034 Executive Officer Director Donald Mowat 11335 NE 122nd Suite 105 Kirkland WA WASHINGTON 98034 Director Mark Burns 11335 NE 122nd Suite 105 Kirkland WA WASHINGTON 98034 Executive Officer Director Biotechnology Decline to Disclose 06b false 2014-06-26 false true true true false 0 1750000 1592697 157303 false 22 0 0 0 false Aminex Therapeutics, Inc. Thomas Graham Thomas Graham COO 2014-07-10